Results for tag: "Hormone Antagonist"

The Hormone Antagonist market is a subset of the Endocrine and Metabolic Disorders Drugs market. Hormone antagonists are drugs that block the action of hormones, such as estrogen and testosterone, in the body. These drugs are used to treat a variety of endocrine and metabolic disorders, including prostate cancer, breast cancer, and infertility. Hormone antagonists are also used to treat conditions such as polycystic ovary syndrome, endometriosis, and precocious puberty. Hormone antagonists are typically administered orally, intramuscularly, or intravenously. They are available in both generic and branded forms. The market for hormone antagonists is expected to grow in the coming years due to the increasing prevalence of endocrine and metabolic disorders. Some of the major companies in the Hormone Antagonist market include Pfizer, Merck, Novartis, AstraZeneca, and Sanofi. Show Less Read more